Dermagraft tissue engineered replacement dermis data

ATIS and partner Smith & Nephew plc announced final data from the pivotal trial of Dermagraft for diabetic foot ulcers at

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE